Loading clinical trials...
Loading clinical trials...
Phase I Trial of Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression
Conditions
Interventions
ExAblate Neuro 4000
Locations
1
Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Start Date
June 25, 2025
Primary Completion Date
September 16, 2027
Completion Date
July 16, 2028
Last Updated
August 6, 2025
NCT04480918
NCT06524505
NCT07172516
NCT06599099
NCT05603104
NCT07246044
Lead Sponsor
Sunnybrook Health Sciences Centre
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions